WHOIS Timeout Confirms Domain Nonexistence; Competitive Landscape Mapped: Owkin, Rhino Health, Apheris, BioIntelliSense Active But No GaudinBrain
Source type:
obs· Harvested: 2026-05-02 · Original date: 2026-05-02T01:27:57.345Z Metadata:{"project":"lunhsiangyuan","type":"discovery","obs_id":64874}
obs/64874 · discovery · 2026-05-02T01:27:57.345Z
WHOIS Timeout Confirms Domain Nonexistence; Competitive Landscape Mapped: Owkin, Rhino Health, Apheris, BioIntelliSense Active But No GaudinBrain
Investigation concluded with definitive domain verification and comprehensive competitive landscape mapping. WHOIS lookup for gaudinbrain.com domain failed with connection timeout error strongly indicating domain does not exist in any public registry. Raphaël Gaudin employment at Braincube confirmed as data-oriented project engineer but Braincube operates in Industry 4.0 industrial manufacturing sector (aeronautics, automotive, AI-driven digital twins) with €83M funding from Scottish Equity Partners and Bpifrance, explicitly NOT healthcare domain. Competitive landscape exhaustively mapped identifying actual operating companies in privacy-preserving AI and continuous monitoring spaces: Owkin (founded 2016, New York) operates federated learning platform for biopharma with open-source Substra framework powering 12-partner voice biomarker diagnostic collaboration; Rhino Health (founded 2020, Boston/Tel Aviv offices) provides federated computing platform with major partnerships including American College of Radiology, NTT DATA strategic partnership, AstraZeneca customer, FL4M (Federated Learning For Medicine) consortium formation, National Cancer Institute Early Detection Research Network participation; Apheris (founded 2019, Berlin) raised Series A $19.9M from Octopus Ventures, Heal Capital, eCAPITAL serving Takeda, AbbVie, Recursion customers, recently launched Apache-licensed OpenFold3 protein co-folding model; BioIntelliSense operates FDA-cleared BioButton continuous monitoring wearable measuring 20+ vital signs with clinical evidence from 15-month study across two hospitals monitoring 11,977 patients totaling 651,000+ patient-hours, achieving 14.8-hour average early detection of patient deterioration, deployed across Houston Methodist’s 2,653 non-ICU beds system-wide with Epic and Cerner EHR integration. Investigation definitively establishes market exists with well-funded, clinically-validated, hospital-deployed competitors operating in exact technical domain described by GaudinBrain MRD (federated learning, privacy-preserving AI, continuous monitoring, edge computing, wearable sensors) but GaudinBrain entity completely absent from ecosystem.
Concepts: [“what-changed”,“how-it-works”]
Facts: [“WHOIS lookup for gaudinbrain.com failed with “connect(): Operation timed out” error indicating domain likely nonexistent or unregistered”,“Raphaël Gaudin confirmed as data-oriented project engineer at Braincube, Industry 4.0 manufacturing company (€83M funding) focused on aeronautics/automotive NOT healthcare”,“Owkin identified as federated learning competitor: founded 2016 New York, biopharma AI platform, open-source Substra framework, 12-partner voice biomarker consortium”,“Rhino Health identified as privacy-preserving federated learning platform: founded 2020 Boston/Tel Aviv, partnerships with American College of Radiology, NTT DATA, AstraZeneca, National Cancer Institute Early Detection Research Network”,“Apheris identified as Berlin-based federated learning company: Series A $19.9M raised, customers Takeda/AbbVie/Recursion, launched Apache-licensed OpenFold3 protein model”,“BioIntelliSense BioButton identified as FDA-cleared continuous monitoring wearable: 20+ vital signs, 651,000 patient-hours monitored, Houston Methodist 2,653-bed deployment, Epic/Cerner EHR integration, 14.8-hour early detection average”]
[← 回 Alfred Brain Hub]